EUVIMEDEUVIMED entdecken
Crossref

Radiation combined with oncolytic vaccinia virus provides pronounced antitumor efficacy and induces immune protection in an aggressive glioblastoma model

Quinn T Storozynsky, Kate C Agopsowicz, Ryan S Noyce, Amirali B Bukhari, Xuefei Han, Natalie Snyder, Brittany A Umer, Armin M Gamper, Roseline Godbout, David H Evans, Mary M Hitt

Cancer Letters · 2023

DOI: 10.1016/j.canlet.2023.216169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2023. Verfasst von Quinn T Storozynsky und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, University of Alberta, Edmonton, AB, Canada; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, AB, Canada; …. Hauptthemen laut MEDLINE: Oncolytic Viruses, Glioblastoma, Oncolytic Virotherapy, Brain Neoplasms. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 80 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GB) is a malignant and immune-suppressed brain cancer that remains incurable despite the current standard of care. Radiotherapy is a mainstay of GB treatment, however invasive cancer cells outside the irradiated field and radioresistance preclude complete eradication of GB cells. Oncolytic virus therapy harnesses tumor-selective viruses to spread through and destroy tumors while stimulating antitumor immune responses, and thus has potential for use following radiotherapy. We demonstrate that oncolytic ΔF4LΔJ2R vaccinia virus (VACV) replicates in and induces cytotoxicity of irradiated brain tumor initiating cells in vitro. Importantly, a single 10 Gy dose of radiation combined with ΔF4LΔJ2R VACV produced considerably superior anticancer effects relative to either monotherapy when treating immune-competent orthotopic CT2A-luc mouse models-significantly extending survival and curing the majority of mice. Mice cured by the combination displayed significantly increased survival relative to naïve age-matched controls following intracranial tumor challenge, with some complete rejections. Further, the combination therapy was associated with an increased ratio of CD8+ effector T cells to regulatory T cells compared to either monotherapy. This study validates the use of radiation with an oncolytic ΔF4LΔJ2R VACV to improve treatment of this malignant brain cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oncolytic VirusesGlioblastomaOncolytic VirotherapyBrain NeoplasmsMiceAnimalsVaccinia virusXenograft Model Antitumor AssaysCell Line, Tumor

Stichwörter der Autor:innen

Antitumor immunityGlioblastomaOncolytic virusesRadiationVaccinia virus

Autor:innen und Institutionen

  • Department of Oncology, University of Alberta, Edmonton, AB, Canada; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, AB, Canada; Cancer Research Institute of Northern Alberta (CRINA), University of A…
  • Department of Oncology, University of Alberta, Edmonton, AB, Canada.
  • Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB, Canada; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, AB, Canada.
  • Department of Oncology, University of Alberta, Edmonton, AB, Canada; Cancer Research Institute of Northern Alberta (CRINA), University of Alberta, Edmonton, AB, Canada.
  • Department of Oncology, University of Alberta, Edmonton, AB, Canada; Department of Neurosurgery, First Hospital of Jilin University, Changchun, China.

Zitieren

APA

Storozynsky, Q. T., Agopsowicz, K. C., Noyce, R. S., Bukhari, A. B., Han, X., Snyder, N., Umer, B. A., Gamper, A. M., Godbout, R., Evans, D. H., & Hitt, M. M. (2023). Radiation combined with oncolytic vaccinia virus provides pronounced antitumor efficacy and induces immune protection in an aggressive glioblastoma model. Cancer Letters. https://doi.org/10.1016/j.canlet.2023.216169

Vancouver

Storozynsky QT, Agopsowicz KC, Noyce RS, Bukhari AB, Han X, Snyder N, et al. Radiation combined with oncolytic vaccinia virus provides pronounced antitumor efficacy and induces immune protection in an aggressive glioblastoma model. Cancer Letters. 2023. doi:10.1016/j.canlet.2023.216169

BibTeX
@article{Storozynsky2023,
  author = {Storozynsky, Quinn T and Agopsowicz, Kate C and Noyce, Ryan S and Bukhari, Amirali B and Han, Xuefei and Snyder, Natalie and Umer, Brittany A and Gamper, Armin M and Godbout, Roseline and Evans, David H and Hitt, Mary M},
  title = {Radiation combined with oncolytic vaccinia virus provides pronounced antitumor efficacy and induces immune protection in an aggressive glioblastoma model},
  journal = {Cancer Letters},
  year = {2023},
  doi = {10.1016/j.canlet.2023.216169}
}
Kostenlos starten →